- Home
- WHWK vs NAUT Comparison
WHWK vs NAUT Comparison
Compare WHWK & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WHWK | NAUT |
|---|---|---|
| Founded | 2007 | 2016 |
| Country | United States | United States |
| Employees | 23 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.4M | 218.6M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | WHWK | NAUT |
|---|---|---|
| Price | $3.75 | $1.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $7.50 | $4.00 |
| AVG Volume (30 Days) | 641.0K | ★ 1.2M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $992.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.57 | $0.62 |
| 52 Week High | $5.50 | $4.31 |
Technical Indicators
Market Signals| Indicator | WHWK | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 38.80 |
| Support Level | $3.70 | $1.61 |
| Resistance Level | $3.79 | $1.87 |
| Average True Range (ATR) | 0.25 | 0.11 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 15.79 | 29.29 |
Price Performance
Historical ComparisonAbout WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.